Electra Director declaration

Director Declaration

31 July 2017

Electra Private Equity PLC announces that John McAdam, a non-executive director of the Company, has been appointed as a Non-executive Director and Senior Independent Director of Cobham plc, effective from 3 August 2017. He will also become a member of the Remuneration and Nomination Committees of Cobham plc.

Electra Private Equity PLC

Categories: Personalia

Schroders completes acquisition of Adveq

Schroder Adveq

Schroders is today announcing the completion of the acquisition of Adveq, a leading asset manager investing in private equity globally.

The acquisition, which was announced on 20 April 2017, has now received approval from the regulators. Adveq has been renamed Schroder Adveq.

The acquisition of Adveq accelerates the growth of Schroders private assets business, with more than $7 billion of client commitments, complementing existing capabilities and expertise in the real estate and infrastructure finance sectors.

Sven Lidén, CEO of Schroder Adveq commented:

“We are pleased to have received such a high level of support from our clients and other stakeholders for our partnership with Schroders.

Schroder Adveq, as we are now known, remains committed to delivering the strong investment performance and high quality client service that investors have come to expect from our team over the 20 years since we first launched.”

Stephen Mills has joined the Schroder Adveq board as Executive Chairman. Bruno Raschle, founder of Schroder Adveq, remains on the board in a new capacity of non-executive Vice Chairman.

Headquartered in Switzerland, Schroder Adveq employs over 100 people around the world. Adveq’s clients include some of the largest and most highly regarded institutional investors and pension funds in Switzerland and Germany. In recent years, Adveq has also successfully established a premium client base in the US and other international markets.

For further information on Schroder Adveq, please contact:

Anelia Fikiina, CNC Communications

Tel: +44 (0)203 219 8887 /  schroderadveq@cnc-communications.com

Categories: News


Marle completes the acquisition of SMB Medical


Marle, the leading European orthopaedic manufacturer backed by IK VII Fund since 2016, is accelerating its development through the acquisition of SMB Medical. Marle acquired 100 percent of the shares of SMB Holding AG, the parent company of SMB Medical SA, from Swiss Patrimonium Private Equity and various minority shareholders. The transaction was closed on 27 July 2016.

Based in Sant’Antonino, Switzerland, and with 85 employees, SMB Medical is a well-established contract manufacturer, producing tailor-made forged orthopaedic implants in all available medical alloys.

Unifying the complementary companies SMB Medical and Marle secures long-term prospects of both brands. Customers will benefit from an extended product range and broader geographic presence. The enlarged group consolidates its rank amongst the top three contract manufacturers for orthopaedic implants worldwide and as the European leader offering one-stop-shop solutions for their customers across the globe.

Heimo Wabusseg, CEO of SMB Medical, is enthusiastic about the acquisition: “by integrating with Marle, SMB Medical will further grow its position in the market by expanding its customer portfolio and investing in new technologies.”

“With SMB Medical, we gain access to attractive new customer segments. SMB Medical offers high quality standards and will enrich the group with a complementary and adjacent product range,” added Antonio Gil, CEO of Marle.

“The acquisition of SMB Medical is a key milestone in the development of Marle, adding additional manufacturing capabilities and a deep understanding of the market,” said Rémi Buttiaux, Partner at IK Investment Partners.

The financial terms of the transaction are not disclosed.

For any questions, please contact:

IK Investment Partners
Mikaela Hedborg
Director Communications & ESG
Phone: +44 77 87 573 566

About Marle
Marle has a 30-year track record serving the orthopaedic implant industry and specialises in the precision forging, machining and finishing of hip knee, shoulder, spine and extremities implants as well as instruments. It has acquired and developed a wide span of technologies dedicated to the medical industry and now offers one of the most comprehensive ranges of manufacturing services in the orthopaedics market. From a modest forging operation with 11 employees in 1978, Marle was shaped into the European leader it is today. For more information, visit www.marle.fr

About SMB Medical
SMB Medical has a history of almost 30 years in the production of orthopaedic and osteosynthesis implants in all available medical grade titanium alloys, cobalt chrome alloys and stainless steels. It uses state-of-the-art technology of forging, machining and finishing processes to develop custom solutions for its clients in the orthopaedic market. For more information, visit www.smb-medical.com

About IK Investment Partners
IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK has raised more than €9 billion of capital and invested in over 100 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit www.ikinvest.com

Categories: News


Hydrawell appoints CEO

No Comments

Hydrawell appoints CEO

28 July 2017 – Rapidly growing plug & abandonment (P&A) and well repair specialists HydraWell has appointed Mark Sørheim as its new chief executive officer.

Mark Sørheim joins HydraWell from Schlumberger in Aberdeen where he held the position as integrated drilling & completion project director. Sørheim has spent almost 20 years in Schlumberger, including management roles in UK, Norway and France as well as operational roles in UK, Colombia and India.

“I have cooperated with HydraWell while at Schlumberger and have been highly impressed. When someone tells you that they can plug a well in 2-3 days instead of the 10-14 days it takes with conventional methods, most people will probably be a bit cautious at first. However, HydraWell’s perf, wash & cement technology does just that. It is by far the oil and gas market’s most cost-efficient P&A solution and I cannot wait to start working with the technology full time,” says Mark Sørheim, newly appointed CEO of HydraWell.

Mark Sørheim succeeds HydraWell’s co-founder Odd Engelsgjerd, who will continue to support the company as business advisor, board member and major shareholder.

“This transition has been planned for some time, by the board of directors and I, as part of our strategy to grow the business further,” says Odd Engelsgjerd.

HydraWell has developed the proprietary PWC®-technology (perforate, wash and cement) that plugs offshore wells in 2-3 days, compared to the traditional method of section milling which takes considerably longer time to complete. So far more than 200+ Hydrasystem plugs have been installed worldwide on behalf of 16 operators including supermajors, majors, NOCs and independent oil companies.

HydraWell is jointly owned by the company’s management and private equity fund Norvestor VII, L.P., which is advised by Norvestor Equity AS – a leading private equity firm focusing on lower mid-market control investments in the Nordic region.

Categories: Personalia


EQT VII to acquire leading specialist mortgage provider BlueStep Bank

  • EQT VII to acquire Sweden based BlueStep Bank, the leading specialist mortgage provider in the Nordic region
  • BlueStep Bank has pioneered the specialist mortgage market in Sweden and Norway, providing more than 29,000 customers with loans since 2005
  • EQT VII will support BlueStep Bank on its continued growth and transformation journey by investing in the organization and supporting further expansion

The EQT VII fund (“EQT VII”) and Bregal Investments (“Bregal”) announced today that EQT VII has entered into an agreement to acquire BlueStep Holding AB (“BlueStep Bank” or “the Company”) from funds managed by Bregal Capital LLP and advised by EMK Capital LLP, and other owners.

Since its foundation in 2005, BlueStep Bank has pioneered the specialist mortgage market in Sweden and Norway. By a differentiated approach to customer on-boarding and loan underwriting, focusing on the customer’s underlying loan servicing ability, BlueStep Bank has provided more than 29,000 customers with loans since inception, building a loan portfolio of SEK 13 billion. BlueStep Bank is headquartered in Stockholm, Sweden and has approximately 200 employees.

“We are very excited to become part of the EQT family”, says Öyvind Thomassen, CEO of BlueStep Bank. “EQT’s entrepreneurial approach, vast sector knowledge and digital capabilities will be of valuable support in our continued growth ambitions”.

Albert Gustafsson, Partner at EQT Partners, Investment Advisor to EQT VII, adds: “We are impressed by BlueStep Bank’s operations, track record and management team. The Company has created the specialist mortgage market in the Nordic region and has a market leading position today. We are convinced that EQT VII is the right partner to support the development of BlueStep Bank by focus and investment into further growth.”

Patrik Johnson, Partner at Bregal Capital LLP and EMK Capital LLP said: “BlueStep Bank is a responsible lender serving an important and growing niche. We are grateful to the management team for their significant achievement in building BlueStep Bank into what it is today and believe that they together with EQT have many exciting opportunities ahead of them”.

The transaction is subject to ownership approval from the Swedish Financial Supervisory Authority and from competition authorities, and is expected to close during fourth quarter of 2017. The parties have agreed not to disclose the transaction value.

Albert Gustafsson, Partner at EQT Partners, Investment Advisor to EQT VII +46 8 506 553 44
Öyvind Thomassen, CEO BlueStep Bank +46 8 501 005 04
EQT Press Office +46 8 506 553 34

About EQT
EQT is a leading alternative investments firm with approximately EUR 37 billion in raised capital across 24 funds. EQT funds have portfolio companies in Europe, Asia and the US with total sales of more than EUR 19 billion and approximately 110,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership.

More info: www.eqtpartners.com

About BlueStep Bank
BlueStep Bank AB (publ) is a Swedish bank with presence in Sweden and Norway. The bank is specialized in catering for the growing share of the population that are not being served by traditional banks. BlueStep focuses on understanding each customers’ situation and their future financial capabilities. BlueStep offers both lending products and deposits. The company has been operating since 2005 and have approximately 200 employees. The Company has its headquarter in Stockholm, an office in Helsingborg and a branch office in Oslo, Norway. BlueStep Bank is licensed by the Swedish Financial Supervisory Authority.

More info: www.bluestepbank.com  

About EMK Capital
EMK Capital LLP is an independent private equity firm, established to continue the investment track record of Edmund Lazarus (previously Founder and Managing Partner of Bregal Capital) and Mark Joseph (previously Founder and Partner at Oakley Capital Private Equity) and to continue to manage portfolio companies of Bregal Capital. EMK is focused on investing in businesses with unrecognised and/or hard to realise value and where EMK can support management teams in executing transformative change. The firm closed its first fund in May 2017 at its hard cap of £575 million.

More info: www.emkcapital.com

About Bregal Investments
Bregal Investments is a global private equity firm which has over US $10 billion in invested or committed capital. The firm invests through several dedicated funds including: Bregal Freshstream, a UK and Benelux focused middle market private equity fund, Bregal Unternehmerkapital, Equity Capital for mid-sized companies in German-speaking Europe, Bregal Partners, a North American middle market private equity fund, Bregal Energy, an Energy-focused private equity fund, Bregal Sagemount, a U.S. private equity fund for growth companies, Bregal Private Equity Partners, a global investor in private equity funds and secondaries.

More info: www.bregal.com


Categories: News


Ardian acquires ~ €300 million infrastructure private equity portfolio from UniCredit

New York, July 28, 2017 – Ardian, the independent private investment company, announces it has signed a Sale and Purchase Agreement in July 2017 with UniCredit for the acquisition of a ~ €300 million portfolio of limited partnership interests in European infrastructure private equity funds. Closing of the transaction is expected in 3Q17 subject to the approval and rules of the fund manager. This deal represents one of the largest secondary infrastructure transactions in 2017 and confirms Ardian’s leadership in secondary infrastructure Funds of Funds.

UniCredit is a simple successful Pan European Commercial Bank, with a fully plugged in CIB, delivering a unique Western, Central and Eastern European network to its extensive client franchise: 25 million clients. UniCredit offers local expertise as well as an international one reaching and supporting its clients globally, providing them with unparalleled access to leading banks in its 14 core markets as well as in other 18 countries worldwide.

This transaction continues Ardian’s secondary funds strategy to offer liquidity to large institutions looking to rebalance their portfolios and monetize their private equity investments. In 2016, the Ardian Fund of Funds team totaled $4.8 billion of secondary, infrastructure secondary and early secondary transactions worldwide.

“This is the culmination of a highly collaborative relationship with UniCredit,” said Mark Benedetti, Managing Director and Co-Head of Ardian US. “This acquisition highlights our unique ability to complete significant and complex transactions which offer secondary liquidity to large institutions such as Unicredit. Our scale and knowledge of the assets meant we were perfectly placed to support its strategy.”

“Our team, spread out across the globe, is able to access a vast amount of information via a database of 1,400 funds and 10,000 underlying companies, which gives us excellent perspective on pricing and quality, allowing us to be opportunistic on behalf of our investors,” said Mark Benedetti.


Ardian, founded in 1996 and led by Dominique Senequier, is an independent private investment company with assets of US$62 billion managed or advised in Europe, North America and Asia. The company, which is majority-owned by its employees, keeps entrepreneurship at its heart and delivers investment performance to its global investors while fuelling growth in economies across the world. Ardian’s investment process embodies three values: excellence, loyalty and entrepreneurship.

Ardian maintains a truly global network, with more than 460 employees working through twelve offices in Beijing, Frankfurt, Jersey, London, Luxembourg, Madrid, Milan, New York, Paris, San Francisco, Singapore and Zurich. The company offers its 580 investors a diversified choice of funds covering the full range of asset classes, including Ardian Funds of Funds (primary, early secondary and secondary), Ardian Private Debt, Ardian North America Direct Buyout, Direct Funds (Ardian Mid Cap Buyout, Ardian Expansion, Ardian Growth, Ardian Co-Investment), Ardian Infrastructure, Ardian Real Estate and customized mandate solutions with Ardian Mandates.



UniCredit is a simple successful Pan European Commercial Bank, with a fully plugged in CIB, delivering a unique Western, Central and Eastern European network to its extensive client franchise: 25 million clients.

UniCredit offers local expertise as well as an international one reaching and supporting its clients globally, providing them with unparalleled access to leading banks in its 14 core markets as well as in other 18 countries worldwide. UniCredit European banking network includes Italy, Germany, Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Hungary, Romania, Russia, Serbia, Slovakia, Slovenia and Turkey.



Categories: News


Acino divests its patch business to Luye Pharma Group Ltd.

Nordic Capital Logo

Acino divests its patch business to Luye Pharma Group Ltd.

Today Acino International AG and Acino Pharma AG (together “Acino”) have signed a definitive agreement with Luye Pharma Group Ltd. (“Luye”) to sell Acino’s transdermal patch and implant businesses. The divestment includes Acino’s transdermal manufacturing operations, distribution, and R&D capabilities.

The divestment is in line with Acino’s strategy of shaping the organization for growth in emerging markets and further expanding Acino’s regional commercial presence in its key markets of the Middle East and Africa, the CIS region, and Latin America.

“The divestment will allow us to focus on growth in our key markets, and we believe that Luye’s vision and strategy will further the expansion of Acino’s existing R&D and manufacturing capabilities in Miesbach. An R&D focused company like Luye will be able to leverage the high potential of our transdermal business in the best possible way in the future, including further global expansion”, says Kalle Känd, CEO at Acino. After closing, Acino will retain the marketing rights to certain transdermal patches in its strategic emerging markets.

“As we execute our international strategy, this transaction serves as an important milestone. With its innovative technology platform, focused product portfolio, loyal customer base and experienced leadership, this acquisition will significantly enhance Luye’s international capabilities and accelerate its penetration into broader therapeutic areas and geographies” said Dr. Yehong Zhang, Luye Pharma (International) CEO.

Closing is expected to occur in the second half of 2016. Approximately 200 employees in Miesbach have been informed about the divestment to Luye during a Town Hall meeting.

About Acino

Acino, a Swiss pharmaceutical company headquartered in Zurich, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino is a leader in advanced drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents.

As a partner of pharmaceutical companies worldwide, Acino supplies finished in-house developed products and/or provides customized one-stop solutions from product development and registration to contract manufacturing, packaging and logistics. Under the brand “Acino Switzerland”, Acino markets Swiss-quality medicines in emerging markets with a focus on the Middle East, Africa, Russia/CIS and Latin America. More information on www.acino-pharma.com

About Luye

Luye Pharma Group Ltd. (the “Company”, together with its subsidiaries collectively the “Group” or “Luye”) focuses on developing, producing, marketing and selling innovative pharmaceutical products in four of the largest and fastest growing therapeutic areas – oncology, cardiovascular, metabolism and the central nervous system(“CNS”) therapeutic area. The Group has 30 product portfolio in the market and 21 product candidates in China and 7 product candidates overseas, among which five candidates have entered into the clinical trial stage in the United States of America (the “U.S.”) under U.S. Food and Drug Administration rules.

The Group has established production facilities and research and development (“R&D”) centers in China as well as offices in US, Malaysia and Singapore with over 3,400 employees, including over 300 R&D personnel. The Group’s products are marketed and sold in a vast majority of provinces, autonomous regions and municipalities in the PRC, as well as a number of foreign countries and regions. The Group’s nationwide sales and distribution network enabled it to sell its products to over 10,000 hospitals in the PRC.

On 9 July 2014, the shares of the Company were listed on the Main Board of the Stock Exchange of Hong Kong Limited. Over the past 22 years, the Group has grown into an international pharmaceutical group with market leading position in its key therapeutic areas. With the corporate value of “Professional Technology Serves Human Health” and the corporate philosophy of “Customer Orientation, Efficiency, and Employee Achievement”, the Group is committed to providing high quality pharmaceutical products and professional services for customers and patients.


Rory Fitzpatrick

Senior Communications Manager

Phone +41 44 555 22 90

Mobile +41 76 411 7138




Categories: News


Partners Group secures EUR 6 billion for direct private equity

Partners Group, the global private markets investment manager, has received record commitments for its 2016/17 direct private equity vintage. The 2016/17 vintage consists of the flagship program Partners Group Direct Equity 2016, which was capped at EUR 3 billion, together with EUR 3 billion of additional capital committed to direct private equity.

Investors in the program constitute a mix of new and existing clients, including public and corporate pension plans, sovereign wealth funds, insurance companies, endowment funds and foundations from around the world. Partners Group’s founders, partners, and other employees, together with affiliates of the firm, are making a substantial investment into the program, committing in excess of 5% of Partners Group Direct Equity 2016.

Partners Group Direct Equity 2016 is the successor to Partners Group Direct Investments 2012, which closed in early 2014 and has a net IRR of 23.9%.1 Like the 2012 program, Partners Group Direct Equity 2016 will be deployed globally on behalf of investors in mid-market and select large-cap companies across a broad range of industry sectors, including healthcare, education, business services, information technology, industrials, and consumer. Partners Group’s investment strategy involves identifying transformative growth trends within specific sub-sectors and finding the companies best-placed to profit from these trends with the help of an active value creation strategy.

David Layton, Partner and Head of Private Equity at Partners Group, states: “In a sluggish macroeconomic environment, we are concentrating our efforts on specific market niches that are experiencing above-average growth. Within these pockets of growth, we look for companies with recurring revenue streams and highly visible cash flows, which are not only well-positioned to perform during a variety of economic scenarios but show significant upside potential and a clear path to value creation.”

Among the transformative trends prioritized within Partners Group’s current relative value outlook are the rise of outsourcing in healthcare and information technology, the digitalization of business services and consumer companies, and the emergence of new business models in consumer services and social infrastructure.

At the time of its final close, Partners Group Direct Equity 2016 was already committed to a number of investments in line with these investment views, including US-based Curvature (formerly Systems Maintenance Services and SMS | Curvature), a global provider of IT network and data center lifecycle services; Cerba HealthCare, a leading European operator of clinical pathology laboratories; and Aavas Financiers (formerly Au Housing Finance), a provider of housing loans in India’s affordable housing segment.

Fredrik Henzler, Partner and Co-Head of Industry Value Creation at Partners Group, comments: “We have more than 160 separate value creation initiatives ongoing at our current lead- and joint-lead portfolio companies. Almost 50% of these are top-line focused projects aimed at increasing market share, while the other 50% are either bottom-line focused efficiency drives or risk-reduction strategies. The extensive sector experience of our global Industry Value Creation team enables us to work alongside management teams to implement such projects and ensure their effectiveness.”

This structured approach to value creation has contributed to measurable results for Partners Group’s existing direct private equity portfolio, which has recorded compound annual growth rates of 15% in terms of revenue and 19% in terms of EBITDA since 2014.2

Christoph Rubeli, Partner and Co-CEO, Partners Group, adds: “We would like to thank our direct private equity investors for placing their trust in our firm in a challenging investment environment characterized by high valuations. With more than 700 private markets platform professionals globally and a highly selective investment approach, we believe we have the sourcing capabilities and the investment discipline required to continue to generate solid returns.”

Categories: News


Allianz, EDF Invest and DIF acquire 6.9 4 % in Autostrade per I’Italia

A consortium made up of Allianz, EDF Invest and DIF have completed the acquisition of a 6.94% stake in Autostrade per I’Italia, the largest Italian toll road network which is majority owned by Atlantia, the listed global operator of motorway and airport infrastructure. This is an increase from the binding agreement to acquire a 5% shareholding announced in April 2017 by use of a call option to acquire additional shares.

The consortium is comprised of long-term infrastructure investors Allianz Capital Partners on behalf of the Allianz Group (60%), EDF Invest (20%) and DIF (20%). Autostrade per I’Italia is the largest toll motorway concession asset in Europe representing more than 50 percent of Italy’s toll motorway network, stretching some 3,000 km stretches across 16 Italian regions comprising 21 toll motorways which cover essential transport links mainly in the Northern part of Italy around the major economic urban areas as well as the two principal north-south routes, the A1 Milan-Naples and the A14 Bologna-Taranto.

Commenting on the closing of this deal, Christian Fingerle, Chief Investment Officer, at Allianz Capital Partners said, “This investment matches our strategy to deliver long-Term benefits to our customers at Allianz. In addition to this, Autostrade per I’Italia has delivered outstanding economic benefits in Italy. We now look forward to working with Atlantia and our consortium partners to facilitate the continued delivery of high-quality service for motorists and commuters.”

Guillaume d’Engremont, Managing Director of EDF Invest said: “EDF Invest is very pleased to complement its portfolio through this investment in ASPI, alongside Tier 1 international investors, and under the continued management of our partner Atlantia.”

Wim Blaasse, Managing Partner of DIF said: “DIF is pleased to invest in this high quality and well diversified road network alongside our consortium partners and to establish this long-term relationship with Atlantia.

Paris, July 26, 2017


About Allianz Capital Partners

Allianz Capital Partners is the Allianz Group’s in-house investment manager for alternative equity investments. With offices in Munich, London, New York and Singapore Allianz Capital Partners manages approximately EUR 18 billion of alternative assets. The investment focus is on infrastructure, renewables as well as private equity funds. ACP’s investment strategy is targeted to generate attractive, long-term and stable returns while diversifying the overall investment portfolio for the Allianz Group insurance companies.

About Allianz

The Allianz Group is one of the world’s leading insurers and asset managers with more than 86 million retail and corporate customers. Allianz customers benefit from a broad range of personal and corporate insurance services, ranging from property, life and health insurance to assistance services to credit insurance and global business insurance. Allianz is one of the world’s largest investors, managing over 650 billion euros on behalf of its insurance customers while our asset managers Allianz Global Investors and PIMCO manage an additional 1.3 trillion euros of third- party assets.

Thanks to our systematic integration of ecological and social criteria in our business processes and investment decisions, we hold a leading position in the Dow Jones Sustainability Index. In 2016, over 140,000 employees in more than 70 countries achieved total revenue of 122 billion euros and an operating profit of 11 billion euros for the group.




About EDF Invest

EDF Invest is the unlisted investment arm of EDF’s Dedicated Assets, the asset portfolio which covers its long-term nuclear decommissioning commitments in France. EDF Invest manages a portfolio of over €5bn equity investments through three asset classes: infrastructure, real estate and private equity.

The existing infrastructure portfolio includes stakes in RTE (the French electricity transmission company), Géosel (an oil storage company based in Manosque), Thyssengas (the third largest gas TSO in Germany), Aéroports de la Côte d’Azur (the second largest French airport operator, owned in partnership with Atlantia), TIGF (a gas transport and storage company operating in the South-West of France), Madrileña Red de Gas (the operator of the main gas distribution network in the region of Madrid) and Porterbrook (one of the three main rolling stock owning companies in the UK).


About DIF

DIF is an independent and specialist fund management company, managing funds of approximately €4.2 billion across seven closed-end investment funds and several co-investment vehicles. DIF’s main funds target PPP / PFI / P3, regulated infrastructure assets and renewable energy projects in Europe, North America and Australasia. DIF has offices in Amsterdam, Frankfurt, London, Paris, Luxembourg, Madrid, Toronto and Sydney.






Categories: News


Procuritas Capital Investors IV divests Oral Care


Procuritas Capital Investors IV LP (“PCI IV” or “Procuritas”) has divested Oral Care Holding SWE AB (“Oral Care”) to Accent Equity 2012 (“Accent”)

Headquartered in Stockholm, Sweden, Oral Care is a leading company in the field of mobile dental care, primarily to elderly people living in specialized housing. In addition, Oral Care operates five dental clinics. In total, Oral Care performs over 90,000 treatments annually and has some 260 employees.

Under Procuritas ownership, Oral Care has transformed from an entrepreneurial organization to a professional player within the field of Swedish dental care. The group has expanded geographically and lately also been active in expanding its network of dental clinics.

“We are pleased to welcome Accent as the new majority owner of Oral Care. The company has good momentum, and we believe that Accent will add great value in further expansion. At the same time, I would like to thank Procuritas for the strategic and financial support during their ownership” says Niclas Palmstierna, CEO of Oral Care.

“During the past seven years, management has done a tremendous job in creating a professional and respected company in the Swedish dental market and we wish them all the best for the future. We are particularly proud of Oral Care’s unique mobile concept that gives elderly people access to dental care that would otherwise not be available to them due to illness or immobility. Today, Oral Care represents a solid platform for Accent to continue the growth path”, comments Mattias Feiff, Partner at Procuritas AB, advisor to PCI IV.

For further information, please contact:

Mattias Feiff, Partner, Procuritas AB, tel. +46 8 506 143 00
Björn Lindberg, Partner, Procuritas AB, tel. +46 8 506 143 00
Niclas Palmstierna, CEO, Oral Care, tel. +46 72-250 20 00

About Procuritas

Founded in 1986, Procuritas was the pioneer in introducing the concept of management buyouts in the Nordic region. In 2016, Procuritas raised Procuritas Capital Investors VI with EUR 318 million under management focusing on investments in Nordic mid-sized companies. The current portfolio consists of thirteen Nordic companies – DSI, Sofa Company, SEM, Dantherm, Daldata, Werksta, Fidelix, Pierce (24 MX), Global Scanning, Farma Holding, Sonans, Gram Equipment and Team Olivia.

Procuritas Capital Investors IV is a private equity fund raised in 2008 focusing on investments in mid-sized companies in the Nordic Region. PCI IV is advised by Procuritas AB and Procuritas Partners GmbH.

Categories: News